ODM-204

· Orion Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ODM-204, covering 2019-12-19 to 2019-12-19. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Pharmacokinetics of ODM-204 in Patients With Metastatic Castration-Resistant Prostate Cancer [Phase 1, Phase 2]

See pricing